Timothy M. Cunningham - Net Worth and Insider Trading

Timothy M. Cunningham Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Timothy M. Cunningham owns 4 companies in total, including Organogenesis Holdings Inc (ORGO) , Alaunos Therapeutics Inc (TCRT) , and Peak Bio Inc (PKBO) among others .

Click here to see the complete history of Timothy M. Cunningham’s form 4 insider trades.

Insider Ownership Summary of Timothy M. Cunningham

Ticker	Comapny	Transaction Date	Type of Owner
ORGO	Organogenesis Holdings Inc	2018-12-10	Chief Financial Officer
TCRT	Alaunos Therapeutics Inc	2021-02-17	interim CFO
PKBO	Peak Bio Inc	2022-11-01	Acting Chief Financial Officer
		2022-11-01	Acting Chief Financial Officer

Timothy M. Cunningham Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Timothy M. Cunningham Ownership Network

Ownership Network List of Timothy M. Cunningham

No Data

Ownership Network Relation of Timothy M. Cunningham

Timothy M. Cunningham Owned Company Details

What does Organogenesis Holdings Inc do?

Who are the key executives at Organogenesis Holdings Inc?

Timothy M. Cunningham is the Chief Financial Officer of Organogenesis Holdings Inc. Other key executives at Organogenesis Holdings Inc include 10 percent owner Albert Erani , 10 percent owner Michael W Katz , and director & President and CEO Gary S. Gillheeney .

Organogenesis Holdings Inc (ORGO) Insider Trades Summary

Over the past 18 months, Timothy M. Cunningham made no insider transaction in Organogenesis Holdings Inc (ORGO). Other recent insider transactions involving Organogenesis Holdings Inc (ORGO) include a net sale of 431,786 shares made by Albert Erani ,

In summary, during the past 3 months, insiders sold 0 shares of Organogenesis Holdings Inc (ORGO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 431,786 shares of Organogenesis Holdings Inc (ORGO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 431,786 shares.

Organogenesis Holdings Inc (ORGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Organogenesis Holdings Inc Insider Transactions

No Available Data

What does Alaunos Therapeutics Inc do?

Who are the key executives at Alaunos Therapeutics Inc?

Timothy M. Cunningham is the interim CFO of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .

Alaunos Therapeutics Inc (TCRT) Insider Trades Summary

Over the past 18 months, Timothy M. Cunningham made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net sale of 68,014 shares made by Boyle Kevin S. Sr. ,

In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 453 shares of Alaunos Therapeutics Inc (TCRT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 453 shares.

Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Alaunos Therapeutics Inc Insider Transactions

No Available Data

What does Peak Bio Inc do?

Who are the key executives at Peak Bio Inc?

Timothy M. Cunningham is the Acting Chief Financial Officer of Peak Bio Inc. Other key executives at Peak Bio Inc include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .

Peak Bio Inc (PKBO) Insider Trades Summary

Over the past 18 months, Timothy M. Cunningham made no insider transaction in Peak Bio Inc (PKBO). Other recent insider transactions involving Peak Bio Inc (PKBO) include a net purchase of 190,250 shares made by Hoyoung Huh ,

In summary, during the past 3 months, insiders sold 0 shares of Peak Bio Inc (PKBO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Peak Bio Inc (PKBO) were sold and 190,250 shares were bought by its insiders, resulting in a net purchase of 190,250 shares.

Peak Bio Inc (PKBO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Peak Bio Inc Insider Transactions

No Available Data

What does Ignyte Acquisition Corp do?

Who are the key executives at Ignyte Acquisition Corp?

Timothy M. Cunningham is the Acting Chief Financial Officer of Ignyte Acquisition Corp. Other key executives at Ignyte Acquisition Corp include General Counsel Peter David Mccabe , 10 percent owner Sbi Kis 2016-1 Fund , and 10 percent owner 2014 Kif-sbi It Investment Fund .

Ignyte Acquisition Corp (IGNYU) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ignyte Acquisition Corp (IGNYU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ignyte Acquisition Corp (IGNYU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ignyte Acquisition Corp (IGNYU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Ignyte Acquisition Corp Insider Transactions

No Available Data

Timothy M. Cunningham Mailing Address

Above is the net worth, insider trading, and ownership report for Timothy M. Cunningham. You might contact Timothy M. Cunningham via mailing address: C/o Organogenesis Inc., 85 Dan Road, Canton Ma 02021.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.